Yanfang Pan

Dr. Yanfang Pan

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2023 in Heliyon
Verified
Journal Article
Open access
YYYaqian Yang
Yaqian Yang
XJXiaotao Jia
Xiaotao Jia
MQMengyang Qu
Mengyang Qu
XYXinmao Yang
Xinmao Yang
YFYan Fang
Yan Fang
YPYanfang Pan
Yanfang Pan
Chronic liver disease is a significant public health issue that can lead to considerable morbidity and mortality, imposing an enormous burden on healthcare resources. Understanding the mechanisms underlying chronic liver disease pathogenesis and developing effective treatment strategies are urgently needed. In this regard, the activation of liver resident macrophages, namely Kupffer cells, plays a vital role in liver inflammation and fibrosis. Macrophages display remarkable plasticity and can polarize into different phenotypes according to diverse microenvironmental stimuli. The polarization of macrophages into M1 pro-inflammatory or M2 anti-inflammatory phenotypes is regulated by complex signaling pathways such as the PI3K/Akt pathway. This review focuses on investigating the potential of using plant chemicals targeting the PI3K/Akt pathway for treating chronic liver disease while elucidating the polarization mechanism of macrophages under different microenvironments. Studies have demonstrated that inhibiting M1-type macrophage polarization or promoting M2-type polarization can effectively combat chronic liver diseases such as alcoholic liver disease, non-alcoholic fatty liver disease, and liver fibrosis. The PI3K/Akt pathway acts as a pivotal modulator of macrophage survival, migration, proliferation, and their responses to metabolism and inflammatory signals. Activating the PI3K/Akt pathway induces anti-inflammatory cytokine expression, resulting in the promotion of M2-like phenotype to facilitate tissue repair and resolution of inflammation. Conversely, inhibiting PI3K/Akt signaling could enhance the M1-like phenotype, which exacerbates liver damage. Targeting the PI3K/Akt pathway has tremendous potential as a therapeutic strategy for regulating macrophage polarization and activity to treat chronic liver diseases with plant chemicals, providing new avenues for liver disease treatment.

1 May 2016 in Physiology & Behavior
Verified
Journal Article
Closed access
XJXiao-Tao Jia
Xiao-Tao Jia
YTYe- Tian
Ye- Tian
YLYuan- Li
Yuan- Li
GZGe-Juan Zhang
Ge-Juan Zhang
ZLZhi-Qin Liu
Zhi-Qin Liu
YPYanfang Pan
Yanfang Pan

8 April 2024 in Brain Research
Verified
Journal Article
Closed access
YYYaqian Yang
Yaqian Yang
XJXiaotao Jia
Xiaotao Jia
XYXinmao Yang
Xinmao Yang
JWJie Wang
Jie Wang
YFYan Fang
Yan Fang
YPYanfang Pan
Yanfang Pan

2 February 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
XYXinmao Yang
Xinmao Yang
JWJie Wang
Jie Wang
XJXiaotao Jia
Xiaotao Jia
YYYaqian Yang
Yaqian Yang
YFYan Fang
Yan Fang
YPYanfang Pan
Yanfang Pan
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β plaques, neurofibrillary tangles, and chronic neuroinflammation. Microglial cells, the resident immune cells in the central nervous system, play a crucial role in the pathogenesis of AD. Microglia can undergo polarization, shifting between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes in response to different stimuli. Dysregulation of microglial polarization towards the pro-inflammatory phenotype leads to the release of inflammatory cytokines, oxidative stress, and synaptic dysfunction. These processes contribute to neuronal damage and cognitive decline in AD. However, several challenges remain in this field. The complex molecular mechanisms governing microglial polarization in AD need to be further elucidated. In this review, we discuss the mechanisms underlying microglial polarization in AD and its implications in disease progression.

21 October 2025 in Molecular Medicine Reports
Verified
Journal Article
Closed access
JWJie Wang
Jie Wang
YLYu Liang
Yu Liang
XJXiaotao Jia
Xiaotao Jia
XYXinmao Yang
Xinmao Yang
DSDanning Shi
Danning Shi
YPYanfang Pan
Yanfang Pan
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, represents a substantial global health challenge with limited treatment options. The voltage‑dependent anion channel (VDAC), a critical mitochondrial outer membrane protein, has emerged as a pivotal regulator in HCC pathogenesis. Dysregulation of VDAC expression and function disrupts mitochondrial metabolism, confers resistance to apoptosis and promotes tumor proliferation. Mechanistically, VDAC facilitates HCC progression through metabolic reprogramming, evasion of programmed cell death and crosstalk with multiple oncogenic signaling pathways. Current VDAC‑targeted therapeutic approaches, including small‑molecule inhibitors and metabolic modulators, have demonstrated promising preclinical efficacy in inducing apoptosis and suppressing tumor growth. Notably, these agents may overcome therapeutic resistance and exhibit synergistic effects with conventional therapies. However, several challenges persist, particularly in elucidating isoform‑specific functions, optimizing pharmacokinetic profiles and identifying predictive biomarkers for patient stratification. The present comprehensive review critically evaluates the mechanistic involvement of VDAC in HCC progression, assesses emerging targeting strategies and proposes future research directions to establish VDAC as a viable precision medicine target for HCC management.

15 April 2021
Verified
Conference Paper
Open access
PDF file
MQMeng-Yang Qu
Meng-Yang Qu
YPYanfang Pan
Yanfang Pan
MXMin Xie
Min Xie
Intestinal microecology refers to the interaction between the host and the microorganisms in the human intestinal tract, which is composed mainly of intestinal flora. Intestinal microflora affects the physiological and pathological changes of the host through metabolic activity and host interaction. Precancerous lesion of liver is a potential benign liver disease, which may lead to malignant transformation of liver. It is the intermediate stage from benign lesion to malignant transformation. Recent studies have shown that intestinal microecology is closely related to the occurrence of precancerous lesions of the liver. This study expounds the interaction of the bridge between intestine and liver, the gutliver axis, the intestinal microecology and the precancerous lesions of liver, hoping to provide a new idea for clinical prevention and treatment of precancerous lesions of liver.